Citius Pharmaceuticals, Inc. Management Fee Expense
Citius Pharmaceuticals, Inc. (CTXR) reported Management Fee Expense of $90.00 thousand for the 9-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ManagementFeeExpense · last filed 2026-08-14
- Citius Pharmaceuticals, Inc. management fee expense for the quarter ending 2025-09-30 was $0.00.
- Citius Pharmaceuticals, Inc. management fee expense for the quarter ending 2024-09-30 was $0.00.
- Citius Pharmaceuticals, Inc. management fee expense for the quarter ending 2024-06-30 was $0.00.
- Citius Pharmaceuticals, Inc. management fee expense for the quarter ending 2024-03-31 was $0.00.
| Period end | Management Fee Expense 3 month | Management Fee Expense 6 month | Management Fee Expense 9 month | Management Fee Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $90.00K 10-Q · filed 2026-08-14 | |||
| 2025-09-30 | $0.00 derived: 10-Q 12 month − 10-Q 9 month · filed 2026-08-14 | $90.00K 10-Q · filed 2026-08-14 | ||
| 2025-06-30 | $90.00K 10-Q · filed 2025-08-12 | |||
| 2024-09-30 | $0.00 derived: 10-Q 12 month − 10-Q 9 month · filed 2026-05-15 | $0.00 derived: sum of 2 quarters · filed 2026-05-15 | $0.00 derived: sum of 3 quarters · filed 2026-05-15 | $90.00K 10-Q · filed 2026-05-15 |
| 2024-06-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-08-12 | $0.00 derived: sum of 2 quarters · filed 2025-08-12 | $90.00K 10-Q · filed 2025-08-12 | |
| 2024-03-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-05-14 | $90.00K 10-Q · filed 2025-05-14 | ||
| 2023-12-31 | $90.00K 10-Q · filed 2025-02-14 | |||
| 2023-03-31 | $90.00K 10-Q · filed 2025-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |